Beauty Health (NASDAQ:SKIN) Issues Quarterly Earnings Results, Beats Expectations By $0.04 EPS

Beauty Health (NASDAQ:SKIN) issued its quarterly earnings data on Thursday. The company reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.09) by $0.04, Zacks reports. Beauty Health had a negative return on equity of 8.97% and a negative net margin of 2.03%.The business had revenue of $64.91 million for the quarter, compared to the consensus estimate of $66.28 million.

Here are the key takeaways from Beauty Health’s conference call:

• Device placements were weaker than expected, prompting a revised full-year revenue outlook to $280 million–$295 million (about a 2.5% reduction); management says Q2 softness will likely persist while commercial fixes take time to translate to results.
• Q1 adjusted EBITDA outperformed at $8.5 million (up 17% YoY) with an adjusted gross margin of 72.2%, and the company is maintaining its full-year adjusted EBITDA guidance of $35M–$45M.
• The active installed base grew to 36,400 devices (up 4% YoY) and device churn declined ~40% YoY, signaling improved provider retention and resilience in recurring consumables revenue.
• Management is enacting commercial and leadership changes (CEO taking a direct sales role and three new independent directors) and advancing an innovation roadmap — relaunching Keravive next quarter, a clinically backed booster in Q4, strategic partnerships, and a next‑gen Hydrafacial targeted for 2028 — initiatives that are promising but expected to take time to impact growth.

Beauty Health Stock Down 36.3%

Shares of NASDAQ SKIN traded down $0.33 during mid-day trading on Friday, hitting $0.58. The company had a trading volume of 4,762,649 shares, compared to its average volume of 830,282. The company has a market capitalization of $74.11 million, a PE ratio of -3.41 and a beta of 1.12. The firm has a 50-day simple moving average of $0.98 and a two-hundred day simple moving average of $1.24. The company has a current ratio of 1.66, a quick ratio of 1.40 and a debt-to-equity ratio of 3.94. Beauty Health has a one year low of $0.57 and a one year high of $2.69.

Wall Street Analyst Weigh In

SKIN has been the topic of several recent research reports. Zacks Research raised Beauty Health from a “strong sell” rating to a “hold” rating in a research note on Monday, March 16th. Jefferies Financial Group reissued a “hold” rating and issued a $1.60 price target on shares of Beauty Health in a research note on Wednesday, January 14th. Benchmark reissued a “hold” rating on shares of Beauty Health in a research note on Friday, March 13th. Canaccord Genuity Group dropped their price target on Beauty Health from $1.50 to $1.00 and set a “hold” rating on the stock in a research note on Friday, May 1st. Finally, TD Cowen dropped their price target on Beauty Health from $1.65 to $1.50 and set a “hold” rating on the stock in a research note on Monday, March 16th. One investment analyst has rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $2.32.

Hedge Funds Weigh In On Beauty Health

Hedge funds have recently modified their holdings of the stock. HRT Financial LP bought a new position in shares of Beauty Health in the 4th quarter valued at about $47,000. Cerity Partners LLC bought a new position in shares of Beauty Health in the 4th quarter valued at about $64,000. Franklin Resources Inc. grew its holdings in shares of Beauty Health by 157.1% in the 4th quarter. Franklin Resources Inc. now owns 39,654 shares of the company’s stock valued at $55,000 after acquiring an additional 24,231 shares in the last quarter. Algert Global LLC bought a new position in shares of Beauty Health in the 3rd quarter valued at about $68,000. Finally, BNP Paribas Financial Markets grew its holdings in shares of Beauty Health by 256.4% in the 3rd quarter. BNP Paribas Financial Markets now owns 38,361 shares of the company’s stock valued at $76,000 after acquiring an additional 27,597 shares in the last quarter. Institutional investors own 93.26% of the company’s stock.

Trending Headlines about Beauty Health

Here are the key news stories impacting Beauty Health this week:

• Positive Sentiment: Q1 adjusted loss per share of $0.05 beat the consensus estimate of a $0.09 loss, showing better-than-expected profitability versus Wall Street expectations.
• Positive Sentiment: The company said it sees Q2 2026 revenue of $72 million to $77 million, which is roughly in line with estimates and suggests some near-term stability.
• Neutral Sentiment: Investor attention is also on the company’s first-quarter earnings call and conference materials for more detail on demand trends, margins, and the outlook for its Hydrafacial brand. SkinHealth Systems Reports First Quarter 2026 Financial Results
• Negative Sentiment: Q1 revenue of $64.91 million missed analyst expectations of $66.28 million, which points to softer-than-expected sales performance.
• Negative Sentiment: The company also guided full-year 2026 revenue to $280 million-$295 million, below the consensus estimate of $296.5 million, signaling slower growth ahead.

Beauty Health Company Profile

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.